Which has better earnings & valuation, FEIM or ALMR?

Frequency Electronics has higher earnings, but lower revenue than Alamar Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Frequency Electronics $69.81M 9.72 $23.69M $0.75 91.96 Alamar Biosciences $87.16M 18.24 N/A N/A N/A

Frequency Electronics (FEIM) Competitors

$68.97 -0.76 (-1.09%)

As of 06/23/2026 04:00 PM Eastern

Compare

FEIM vs. ALNT, ALMR, EYPT, TRNS, and CTKB

Should you buy Frequency Electronics stock or one of its competitors? MarketBeat compares Frequency Electronics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Frequency Electronics include Allient (ALNT), Alamar Biosciences (ALMR), Eyepoint Pharmaceuticals (EYPT), Transcat (TRNS), and Cytek Biosciences (CTKB). These companies are all part of the "measuring and control equipment" industry.

How does Frequency Electronics compare to Allient?

Allient (NASDAQ:ALNT) and Frequency Electronics (NASDAQ:FEIM) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations.

Allient presently has a consensus target price of $77.33, indicating a potential downside of 19.47%. Frequency Electronics has a consensus target price of $43.67, indicating a potential downside of 36.69%. Given Allient's higher probable upside, analysts clearly believe Allient is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allient	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

Allient has a beta of 1.63, indicating that its stock price is 63% more volatile than the broader market. Comparatively, Frequency Electronics has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market.

Frequency Electronics has lower revenue, but higher earnings than Allient. Allient is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allient	$554.48M	2.94	$22.03M	$1.43	67.15
Frequency Electronics	$69.81M	9.72	$23.69M	$0.75	91.96

Frequency Electronics has a net margin of 10.78% compared to Allient's net margin of 4.25%. Frequency Electronics' return on equity of 12.69% beat Allient's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allient	4.25%	12.47%	6.37%
Frequency Electronics	10.78%	12.69%	7.84%

In the previous week, Allient had 3 more articles in the media than Frequency Electronics. MarketBeat recorded 3 mentions for Allient and 0 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 1.00 beat Allient's score of 0.09 indicating that Frequency Electronics is being referred to more favorably in the news media.

Company	Overall Sentiment
Allient	Neutral
Frequency Electronics	Positive

61.6% of Allient shares are owned by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are owned by institutional investors. 15.0% of Allient shares are owned by company insiders. Comparatively, 28.0% of Frequency Electronics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Frequency Electronics beats Allient on 10 of the 17 factors compared between the two stocks.

How does Frequency Electronics compare to Alamar Biosciences?

Frequency Electronics (NASDAQ:FEIM) and Alamar Biosciences (NASDAQ:ALMR) are both small-cap measuring and control equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

58.6% of Frequency Electronics shares are held by institutional investors. 28.0% of Frequency Electronics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Frequency Electronics currently has a consensus price target of $43.67, suggesting a potential downside of 36.69%. Alamar Biosciences has a consensus price target of $30.00, suggesting a potential upside of 30.78%. Given Alamar Biosciences' higher probable upside, analysts plainly believe Alamar Biosciences is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Frequency Electronics has higher earnings, but lower revenue than Alamar Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Frequency Electronics	$69.81M	9.72	$23.69M	$0.75	91.96
Alamar Biosciences	$87.16M	18.24	N/A	N/A	N/A

In the previous week, Frequency Electronics' average media sentiment score of 1.00 beat Alamar Biosciences' score of 0.00 indicating that Frequency Electronics is being referred to more favorably in the media.

Company	Overall Sentiment
Frequency Electronics	Positive
Alamar Biosciences	Neutral

Frequency Electronics has a net margin of 10.78% compared to Alamar Biosciences' net margin of 0.00%. Frequency Electronics' return on equity of 12.69% beat Alamar Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Frequency Electronics	10.78%	12.69%	7.84%
Alamar Biosciences	N/A	N/A	N/A

Summary

Frequency Electronics beats Alamar Biosciences on 8 of the 12 factors compared between the two stocks.

How does Frequency Electronics compare to Eyepoint Pharmaceuticals?

Frequency Electronics (NASDAQ:FEIM) and Eyepoint Pharmaceuticals (NASDAQ:EYPT) are both small-cap measuring and control equipment companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation and profitability.

In the previous week, Eyepoint Pharmaceuticals had 1 more articles in the media than Frequency Electronics. MarketBeat recorded 1 mentions for Eyepoint Pharmaceuticals and 0 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 1.00 beat Eyepoint Pharmaceuticals' score of 0.00 indicating that Frequency Electronics is being referred to more favorably in the media.

Company	Overall Sentiment
Frequency Electronics	Positive
Eyepoint Pharmaceuticals	Neutral

Frequency Electronics currently has a consensus price target of $43.67, suggesting a potential downside of 36.69%. Eyepoint Pharmaceuticals has a consensus price target of $31.80, suggesting a potential upside of 121.14%. Given Eyepoint Pharmaceuticals' higher possible upside, analysts plainly believe Eyepoint Pharmaceuticals is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00
Eyepoint Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	3.00

58.6% of Frequency Electronics shares are held by institutional investors. Comparatively, 99.4% of Eyepoint Pharmaceuticals shares are held by institutional investors. 28.0% of Frequency Electronics shares are held by insiders. Comparatively, 5.1% of Eyepoint Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Frequency Electronics has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market. Comparatively, Eyepoint Pharmaceuticals has a beta of 1.72, meaning that its stock price is 72% more volatile than the broader market.

Frequency Electronics has a net margin of 10.78% compared to Eyepoint Pharmaceuticals' net margin of -3,566.63%. Frequency Electronics' return on equity of 12.69% beat Eyepoint Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Frequency Electronics	10.78%	12.69%	7.84%
Eyepoint Pharmaceuticals	-3,566.63%	-110.54%	-90.15%

Frequency Electronics has higher revenue and earnings than Eyepoint Pharmaceuticals. Eyepoint Pharmaceuticals is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Frequency Electronics	$69.81M	9.72	$23.69M	$0.75	91.96
Eyepoint Pharmaceuticals	$31.37M	38.43	-$231.96M	-$3.50	N/A

Summary

Frequency Electronics beats Eyepoint Pharmaceuticals on 9 of the 16 factors compared between the two stocks.

How does Frequency Electronics compare to Transcat?

Frequency Electronics (NASDAQ:FEIM) and Transcat (NASDAQ:TRNS) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership.

Frequency Electronics has higher earnings, but lower revenue than Transcat. Frequency Electronics is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Frequency Electronics	$69.81M	9.72	$23.69M	$0.75	91.96
Transcat	$331.88M	2.52	$5.38M	$0.58	154.24

In the previous week, Transcat had 3 more articles in the media than Frequency Electronics. MarketBeat recorded 3 mentions for Transcat and 0 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 1.00 beat Transcat's score of 0.16 indicating that Frequency Electronics is being referred to more favorably in the media.

Company	Overall Sentiment
Frequency Electronics	Positive
Transcat	Neutral

Frequency Electronics currently has a consensus price target of $43.67, indicating a potential downside of 36.69%. Transcat has a consensus price target of $105.33, indicating a potential upside of 17.74%. Given Transcat's higher probable upside, analysts clearly believe Transcat is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00
Transcat	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

58.6% of Frequency Electronics shares are owned by institutional investors. Comparatively, 98.3% of Transcat shares are owned by institutional investors. 28.0% of Frequency Electronics shares are owned by insiders. Comparatively, 2.8% of Transcat shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Frequency Electronics has a net margin of 10.78% compared to Transcat's net margin of 1.62%. Frequency Electronics' return on equity of 12.69% beat Transcat's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Frequency Electronics	10.78%	12.69%	7.84%
Transcat	1.62%	5.84%	3.78%

Frequency Electronics has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market. Comparatively, Transcat has a beta of 0.71, indicating that its stock price is 29% less volatile than the broader market.

Summary

Frequency Electronics beats Transcat on 9 of the 16 factors compared between the two stocks.

How does Frequency Electronics compare to Cytek Biosciences?

Cytek Biosciences (NASDAQ:CTKB) and Frequency Electronics (NASDAQ:FEIM) are both small-cap measuring and control equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Cytek Biosciences currently has a consensus price target of $5.69, suggesting a potential upside of 39.74%. Frequency Electronics has a consensus price target of $43.67, suggesting a potential downside of 36.69%. Given Cytek Biosciences' higher probable upside, equities analysts plainly believe Cytek Biosciences is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cytek Biosciences	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

Frequency Electronics has a net margin of 10.78% compared to Cytek Biosciences' net margin of -36.25%. Frequency Electronics' return on equity of 12.69% beat Cytek Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cytek Biosciences	-36.25%	-10.07%	-7.56%
Frequency Electronics	10.78%	12.69%	7.84%

Cytek Biosciences has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market. Comparatively, Frequency Electronics has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market.

In the previous week, Cytek Biosciences had 1 more articles in the media than Frequency Electronics. MarketBeat recorded 1 mentions for Cytek Biosciences and 0 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 1.00 beat Cytek Biosciences' score of 0.76 indicating that Frequency Electronics is being referred to more favorably in the news media.

Company	Overall Sentiment
Cytek Biosciences	Positive
Frequency Electronics	Positive

69.5% of Cytek Biosciences shares are held by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are held by institutional investors. 10.4% of Cytek Biosciences shares are held by company insiders. Comparatively, 28.0% of Frequency Electronics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Frequency Electronics has lower revenue, but higher earnings than Cytek Biosciences. Cytek Biosciences is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cytek Biosciences	$201.49M	2.61	-$66.54M	-$0.57	N/A
Frequency Electronics	$69.81M	9.72	$23.69M	$0.75	91.96

Summary

Frequency Electronics beats Cytek Biosciences on 11 of the 17 factors compared between the two stocks.

Get Frequency Electronics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FEIM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FEIM vs. The Competition

Export

Metric	Frequency Electronics	INSTRU Industry	Computer Sector	NASDAQ Exchange
Market Cap	$686.28M	$3.34B	$39.31B	$12.39B
Dividend Yield	N/A	0.95%	3.27%	5.83%
P/E Ratio	91.96	75.68	79.23	23.99
Price / Sales	9.72	3.74	624.36	107.77
Price / Cash	26.09	27.63	48.53	54.51
Price / Book	11.99	4.25	9.58	6.50
Net Income	$23.69M	$73.46M	$1.07B	$336.88M
7 Day Performance	-1.78%	-1.26%	-0.81%	-0.14%
1 Month Performance	1.41%	4.60%	0.98%	0.77%
1 Year Performance	207.90%	68.24%	156.63%	28.49%

Frequency Electronics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FEIM Frequency Electronics	1.5968 of 5 stars	$68.97 -1.1%	$43.67 -36.7%	+196.8%	$686.28M	$69.81M	91.96	200	Positive News Gap Down
ALNT Allient	2.4509 of 5 stars	$95.58 +0.5%	$77.33 -19.1%	+177.5%	$1.63B	$554.48M	67.18	2,478	Gap Down
ALMR Alamar Biosciences	4.3166 of 5 stars	$20.25 -2.1%	$30.00 +48.1%	N/A	$1.40B	$87.16M	N/A	222	Positive News
EYPT Eyepoint Pharmaceuticals	2.0845 of 5 stars	$12.39 +2.5%	$31.80 +156.8%	+73.7%	$1.04B	$31.37M	N/A	120
TRNS Transcat	3.2907 of 5 stars	$91.52 -0.1%	$105.33 +15.1%	+11.4%	$856.21M	$331.88M	158.06	1,413

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FEIM) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Frequency Electronics (FEIM) Competitors

FEIM vs. ALNT, ALMR, EYPT, TRNS, and CTKB

How does Frequency Electronics compare to Allient?

Summary

How does Frequency Electronics compare to Alamar Biosciences?

Summary

How does Frequency Electronics compare to Eyepoint Pharmaceuticals?

Summary

How does Frequency Electronics compare to Transcat?

Summary

How does Frequency Electronics compare to Cytek Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FEIM vs. The Competition

Frequency Electronics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Frequency Electronics (FEIM) Competitors

FEIM vs. ALNT, ALMR, EYPT, TRNS, and CTKB

How does Frequency Electronics compare to Allient?

Do analysts recommend ALNT or FEIM?

Which has more risk and volatility, ALNT or FEIM?

Which has higher earnings & valuation, ALNT or FEIM?

Is ALNT or FEIM more profitable?

Does the media refer more to ALNT or FEIM?

Do insiders & institutionals have more ownership in ALNT or FEIM?

Summary

How does Frequency Electronics compare to Alamar Biosciences?

Do insiders & institutionals believe in FEIM or ALMR?

Do analysts recommend FEIM or ALMR?

Which has better earnings & valuation, FEIM or ALMR?

Does the media prefer FEIM or ALMR?

Is FEIM or ALMR more profitable?

Summary

How does Frequency Electronics compare to Eyepoint Pharmaceuticals?

Does the media prefer FEIM or EYPT?

Do analysts rate FEIM or EYPT?

Do institutionals & insiders believe in FEIM or EYPT?

Which has more volatility & risk, FEIM or EYPT?

Is FEIM or EYPT more profitable?

Which has stronger valuation and earnings, FEIM or EYPT?

Summary

How does Frequency Electronics compare to Transcat?

Which has stronger earnings and valuation, FEIM or TRNS?

Does the media prefer FEIM or TRNS?

Do analysts rate FEIM or TRNS?

Do insiders & institutionals have more ownership in FEIM or TRNS?

Is FEIM or TRNS more profitable?

Which has more risk & volatility, FEIM or TRNS?

Summary

How does Frequency Electronics compare to Cytek Biosciences?

Do analysts rate CTKB or FEIM?

Is CTKB or FEIM more profitable?

Which has more risk and volatility, CTKB or FEIM?

Does the media refer more to CTKB or FEIM?

Do institutionals & insiders hold more shares of CTKB or FEIM?

Which has preferable valuation & earnings, CTKB or FEIM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FEIM vs. The Competition

Frequency Electronics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools